Investor mix
7 investors on record; lead investors include Frontline BioVentures, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 86% |
| Other / undisclosed | 1 | 14% |
Developer of high throughput gene sequencing platform for clinical application
7 investors on record; lead investors include Frontline BioVentures, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 86% |
| Other / undisclosed | 1 | 14% |